Agenda/Scientific Program

View the Scientific Program

The 2024 Mass Spectrometry (Mass Spec) Symposium will bring together industry, academia, and regulatory agencies from around the world to discuss best practices and innovative approaches for mass spectrometry applications in the discovery, development, and commercialization of biopharmaceuticals. Speaker presentations, panel discussions, and poster sessions will give you the opportunity to engage with fellow attendees in meaningful discussions. We look forward to an informative Symposium and hope to see you there. Be ready to network, collaborate, and expand your knowledge.

Keynote Speakers

Mass Spectrometry Symposium Keynote Speakers Joshua Coon University of Madison-Wisconsin John Valliere-Douglass Pfizer, Inc.

Click on the section below for more information:

 

Keynote Speakers Bios

Joshua Coon

Professor of Chemistry and Biomolecular Chemistry
University of Madison-Wisconsin

Bio coming soon.

John Valliere-Douglass

Senior Director of Analytical Sciences
Pfizer, Inc.

John Valliere-Douglass is a Senior Director of Analytical Sciences at Pfizer, Inc. John received a BSc degree in biochemistry from Western WA University in 1997 and has worked in the biotechnology industry for 27 years in various roles involving the use of mass spectrometry for antigen discovery and biotherapeutic protein characterization. In 2011, Valliere-Douglass became the mass spectrometry core group leader at Seagen (now Pfizer) where he built a team of scientists that focused on advancing ADC characterization and providing high-throughput process-analytical support with mass spectrometry. In 2022, Valliere-Douglass became the head of Analytical Sciences where he continues to oversee release and stability method development and further integration of mass spectrometry into early development and characterization of ADCs. Over the course of his career, he has been involved with the CASSS Mass Spec Symposium on the organizing committee and as a conference co-chair and has authored or co-authored more than 30 publications covering various aspects of protein, antibody, and ADC characterization with mass spectrometry.

 

Short Course | Tuesday, September 10, 2024

Session I: Fundamentals of Mass Spectrometry in the Analysis of Protein Therapeutics | 08:30 - 12:00 EST
Session II: Applications of Mass Spectrometry to Characterize Biotherapeutics | 13:00 - 16:30 EST

Instructors
Chris Chumsae, Bristol Myers Squibb-Company
Andy Mahan, Johnson & Johnson
Rich Rogers, Umoja Biopharma

The Short Course Session I and Session II will take place on Tuesday, September 10, 2024 at the Bethesda North Marriott Hotel & Conference Center and will be offered in-person only.

More Information      Register Now

Note: Registration for the short course is an additional cost not included in the conference registration fee. For additional information on pricing, view Registration Fees.

 

Save the Date

Mark your calendars for Mass Spec 2024 on September 10-13, 2024 in Rockville, MD. Registration will be available soon.

Red orange background with hexagon molecules and text 'Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry September 10-13 Rockville, MD'

Volunteer for Breakfast Chats or Roundtables

Are you planning to attend, or eager to volunteer? Interested in being a facilitator or scribe for a discussion? We are also looking for volunteers to provide diverse perspectives to the next generation of CASSS leaders. These are great opportunities to become more involved in the CASSS community.

Image with text 'call for casss volunteers'
"Best conference to learn what's happening in industry-based MS groups"
—Wendy Sandoval, Mass Spectrometry 2023 Attendee
"The Mass Spec Symposium is a great opportunity to hear about novel, focused efforts in mass spec of pharmaceuticals and biologics.”
—Anonymous, Mass Spectrometry 2023 Attendee